search button
Open Access

[Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis

  • Authors:
    • Yongqiang Li
    • Shuxin Shen
    • Shoukun Ding
    • Lixia Wang

  • View Affiliations

  • Published online on: November 4, 2024     https://doi.org/10.3892/etm.2024.12760
  • Article Number: 10

  • Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2025
Volume 29 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Shen S, Ding S and Wang L: [Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis. Exp Ther Med 29: 10, 2025.
APA
Li, Y., Shen, S., Ding, S., & Wang, L. (2025). [Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis. Experimental and Therapeutic Medicine, 29, 10. https://doi.org/10.3892/etm.2024.12760
MLA
Li, Y., Shen, S., Ding, S., Wang, L."[Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis". Experimental and Therapeutic Medicine 29.1 (2025): 10.
Chicago
Li, Y., Shen, S., Ding, S., Wang, L."[Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis". Experimental and Therapeutic Medicine 29, no. 1 (2025): 10. https://doi.org/10.3892/etm.2024.12760